Sucrets Complete
This article was originally published in The Tan Sheet
Executive Summary
Sucrets line extension Sucrets Complete is the first reformulation of the 75-year old brand in at least 10 years, according to Insight Pharmaceuticals President & CEO Jeffrey Nugent. The Blue Bell, Penn.-based firm announced the launch of the multi-symptom cough/cold lozenge Sept. 27. With dyclonine, zinc and vitamin C, Sucrets Complete has the "optimal combination of ingredients to satisfy consumer needs," Nugent said. "This is the biggest news, the biggest idea in this category in 25 years." The launch is "the first stage in a complete brand revitalization program" as the company strives to reinforce its message that Sucrets is a "serious solution" for cough, cold and sore throat symptoms. The firm will promote Sucrets Complete through a multimedia advertising campaign involving print and radio ads, scheduled to launch in the mid-October. Available in two flavors, Vapor Cherry and Cool Citrus, Sucrets Complete will retail for $3.49-$4.99...
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.